Basic Information


GTO ID GTC2861
Trial ID NCT05143307
Disease HIV Infection
Altered gene HSV-1 genome
Therapeutic/Target gene Target gene
TherapyGene editing
Treatment EBT-101
PhasePhase1
Recruitment statusEnrolling By Invitation
TitleLong-Term Follow-Up Study of HIV-1 Infected Adults Exiting a Parent Study Where EBT-101 Was Administered
Year2021
CountryUnited States
Company sponsorExcision BioTherapeutics
Other ID(s)EBT-101-002
Vector information
Vectoradeno-associated virus
ConstructAAV9-CRISPR/Cas9
Vector typeadeno-associated virus serotype 9 (AAV9) vector
Transgene/Inserted geneHIV-1-specific clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 gene editing system

Clinical Result

Cohort 1
Administration route intravenous infusion
Pts 9
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph